BSc University of Ottawa, Ottawa, Ontario, Canada

Kaitlyn is responsible for managing the firm and leading the staff of twenty senior consultants and supporting staff. By offering full-service strategic pricing and market access consulting services, Kaitlyn and her team assist clients across all stages of product development.

Kaitlyn has led the development of numerous strategic PMPRB pricing assessments and submissions in a vast array of therapeutic areas and has successfully developed strategies to mitigate/minimize potential exposure during PMPRB investigational matters. She has also led the development successful formulary listing submissions to the CDR, INESSS, F/P/T drug plans, and private payer drug plans and has worked with clients in negotiating product listing agreements (PLAs) with pCPA, public payers (including Quebec) and private payers. She provides ongoing advice with respect to reimbursement strategy and PLA negotiations to help ensure timely listing on drug plan formularies. Kaitlyn maintains a strong working relationship with drug plan managers across Canada facilitating access to payers, decision makers and the latest information on drug plan policies and regulations.

Kaitlyn studied at the University of Ottawa and holds a Bachelor of Science with Honors in Biopharmaceutical Sciences and an option in Genomics. To compliment her science background, Kaitlyn has also taken a number of executive development courses through McGill University. Prior to joining PDCI in 2010, Kaitlyn worked at Health Canada within the Marketed Health Products Directorate in the Regulatory Advertising and Risk Communication Section where she was involved in the dissemination of post-approval risk communications concerning all regulated marketed health products.